Semaglutide is a GLP-1 receptor agonist (the same class as Wegovy and Ozempic) and tirzepatide is a dual GLP-1 and GIP receptor agonist (the class behind Mounjaro and Zepbound)
10.1007/s12325-021-01789-5 [DOI] [PubMed] [Google Scholar] 76.Wall BT, Stephens FB, Constantin-Teodosiu D, Marimuthu K, Macdonald IA, Greenhaff PL
These might seem unrelated at first, but when youre feeling physically uncomfortable or unwell, its tough to stay interested in sex
There is emerging evidence that suggests BPC 157 may support faster recovery in sports-related injuries, though conclusive claims require further scientific validation
April 2026: As of April 1, there are now 73 pending cases in MDL 3163, which involves vision loss (non-arteritic anterior ischemic optic neuropathy) cases filed by people taking GLP-1 drugs, including Zepbound